BusinessHemispherx Biopharma Announces Collaboration with Millions Missing Canada to Bring Medication to Canadians for Myalgic Encephalomyelitis/Chronic Fatigue SyndromeBy Nasdaq OMXAug 8, 2017, 10:08 AM UTC
BusinessHemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue SyndromeBy Nasdaq OMXAug 4, 2017, 12:30 PM UTC
BusinessHemispherx Biopharma Enhances Ampligen Manufacturing and Scientific CapabilitiesBy Nasdaq OMXMay 31, 2017, 3:40 PM UTC
BusinessHemispherx Biopharma Enhances Ampligen Manufacturing and Scientific CapabilitiesBy Nasdaq OMXMay 31, 2017, 3:40 PM UTC
BusinessHemispherx Biopharma Announces Identification of High Responder Patient Subgroup from Ampligen® Phase III Trial in Patients with CFS/MEBy Nasdaq OMXOct 31, 2016, 12:31 PM UTC
